RECENT PRESS
June 9, 2021
Miami, Fla., and San Mateo, Calif., June 9, 2021 — A collaboration between QHM  - Quality Health Management, a global medical cost containment leader, and MORE Health, an expert medical second opinion and collaborative diagnosis service, now offers an advanced second medical opinion (SMO) solution for client companies of QHM.Today, clients of QHM will have easy access to a world-leading second opinion service when making decisions regarding serious life-changing illnesses. Upon client activation, QHM virtually connects the patient's attending doctor with a MORE Health Physician Specialist to jointly develop a comprehensive collaborative diagnosis together with the optimum treatment plan via MORE Health’s outstanding panel of subject matter physician experts in leading centers of excellence around the globe."Through this expert collaboration, QHM is pleased to expand its offering with an innovative next-generation second opinion medical opinion solution for its many clients globally," said Sven Thorslund, Quality Health Management’s Sales Director."As a care-conscious innovator, MORE Health offers a technology-driven collaborative approach to diagnosis and delivers the most effective treatment plan possible," adds MORE Health's Vice President Strategic Partnerships, Pam Frank. "Patients value understanding their options, payors appreciate more clarity, and medical experts at centers of excellence favor our leading-edge imaging and technologies. Our global mindset and culture of caring align very well with QHM to bring cross-border health management to new levels.""The MORE Health service ensures that patients have the correct diagnosis, minimizing any chance of error, and allows them to understand the best possible treatment options before making a decision on the best path forward. This service provides much needed peace of mind for patients and the inclusion of these benefits represents significant added value, savings, and differentiation for health plans, reinsurers and other stakeholders, Thorslund further commented.About QHM InternationalHeadquartered in Miami, FL, QHM - Quality Health Management (QHM) is a medical cost containment company offering specialized services to global healthcare insurers, reinsurers, and governments. QHM has been guiding the global needs of clients, payers and patients with PPO, administrative, and specialty services since 2000. With exceptional experience and expertise in managing the access, quality, and costs of global healthcare, QHM helps protect clients’ bottom line and customer experience through effective and flexible boutiques style solutions for savings and service.About MORE HealthMORE Health, a global digital health company, provides peace of mind and confidence to patients when they need it most—when facing a serious life-changing illness. Delivering second medical opinions virtually, MORE Health delivers a diagnosis and recommended treatment plan from the world’s best medical minds. Offering all the benefits of a second opinion, the service ensures that the attending doctor and the expert physician specialist are aligned through their proprietary, GDPRHIPPA-compliant Physician Collaboration Platform™. Since 2013, MORE Health has helped patients on six continents and continues its mission to provide clients and their members access to the best medical minds in the world—when they need it most. 
June 8, 2021
Just announced: Health Information Resource Center (HIRC) has announced its Spring 2021 Digital Health Awards, honoring the world’s best digital health resources.MORE Health is honored to have received an award in the social media category for its LinkedIn profile. The Digital Health Awards are celebrating their 23rd year and recognize high-quality digital health resources for consumers and health professionals. These awards are an “extension of the HIRC’s National Health Information Awards™, the largest program of its kind in the United States.”Visit MORE Health’s LinkedIn page here: https://www.linkedin.com/company/more-health.About MORE HealthMORE Health, a global digital health company, provides peace of mind and confidence to patients when they need it most—when facing a serious life-changing illness. Delivering second medical opinions virtually, MORE Health delivers a diagnosis and recommended treatment plan from the world’s best medical minds. This collaborative approach to diagnosis puts the patient at the center of the process—empowering them to make informed decisions regarding their healthcare. Offering all the benefits of a second opinion, the service ensures that the attending doctor and the expert physician specialist are aligned through their proprietary, GDPR- and HIPPA-compliant Physician Collaboration Platform™, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan developed. Since 2013, MORE Health has helped patients on six continents and continues its mission to provide clients and their members access to the best medical minds in the world—when they need it most.
April 21, 2021
SAN MATEO, CA – Today, MORE Health, a global digital health company, has announced a “new addition” to their family: MORE Health for Kids. “I refused to accept anyone giving up on a young child,” says Hope Lewis, Co-Founder and CEO of MORE Health. Lewis was working as an international finance attorney when her client’s 18-month-old daughter was diagnosed with a rare childhood cancer. When physicians declared the case hopeless, it was a second opinion and new treatment plan from world-renowned oncologists that provided hope. Today, that little girl is fifteen, healthy, and cancer-free.This story inspired the formation of MORE Health and directed the company’s mission to give people access to the best medical minds in the world when they need it most when facing a serious life-changing illness. Guiding their mission and new brand is Jonathan Finlay, MD, ChB, FRCP. Finlay is a world-renowned pediatric neuro-oncologist, or as he likes to call it, “a child’s brain tumor doctor.” He is an Emeritus Professor of Pediatrics at The Ohio State University College of Medicine and is Principal Investigator of NEXT / Head Start 4 Consortium Trial at Nationwide Children’s Hospital. Among his many awards, he is the first pediatric specialist to receive the Lifetime Achievement Award from the Society of Neuro-Oncology.Finlay will serve as Pediatrician-in-Chief of MORE Health for Kids, providing parents virtual second medical opinions with the leading specialists from world-class academic medical institutions. This service will be delivered through MORE Health’s proprietary digital platform and can be accessed in the U.S. or internationally.“I have worked with families and physicians throughout the world for the last forty years and have seen how devastating cancer can be to a child, parents, and siblings,” Finlay said. He goes on to say, “I’ve also seen how new treatments have provided children with both improved survival rates and improved quality of life—which is why I’m delighted to join MORE Health for Kids to provide children and their families with the highest level of healthcare when they need it most.”For more information, visit MORE Health for Kids.About MORE HealthMORE Health is a global digital health company that provides peace of mind and confidence to make the best healthcare decisions when diagnosed with a serious life-changing illness. The company delivers second medical opinions virtually. MORE Health utilizes its HIPAA-compliant platform to connect patients to a world-leading physician specialist. The service is offered as an employee benefit or on an individual case basis.
September 22, 2020
Whether you are planning a pregnancy, trying to conceive, experiencing a high-risk pregnancy or other related medical issues, we can help. As a company well-versed in leading medical experts, we continue our mission to help when you need it most, now providing patients access to the best medical minds in the world for women's health, endocrinology, high-risk pregnancy, fertility and reproductive healthcare.To learn more about this service or to schedule an appointment, visit Prodigy Fertility. About MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best medical minds in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development.
January 14, 2020
San Mateo, CA, January 14, 2020 -- On Monday, January 13, 2020, the Asia America MultiTechnology Association (AAMA), the largest pan-Asian technology association, hosted a one-day global Healthtech Conference, “AI: The Next Digital Frontier for Healthcare Innovation,” at the Wells Fargo Innovation Hub in San Francisco. It was held in conjunction with the J.P. Morgan Healthcare Conference and was an innovative look at healthcare and the latest global developments in cutting-edge health technology. The J.P. Morgan conference is the largest healthcare investment symposium in the industry, featuring medical trailblazers and disruptive technologies that are accelerating the rate of innovation in healthcare, from lab breakthroughs to new point-of-care technologies.MORE Health, a global healthcare company, was invited to present their new AI product at this year’s AAMA Conference. During MORE Health’s presentation, Chief Medical Consultant Dr. Robert Warren announced the launch of a new Artificial Intelligence (AI) feature on MORE Health’s Physician Collaboration Platform™. This new AI product, AIMA (AI Medical Assistant), brings benefits to both the physician and patient sides of the platform. The new AI component of MORE Health’s technology platform ranks tens of thousands of cases in MORE Health’s databases by similarity and presents treating physicians with treatment plans for cases most similar to the one they are presently treating. For patients, in addition to receiving their MORE Health second opinion report, they will receive recommendations for the most appropriate expert in the field, as well as an overview of similar cases with their treatment plans and outcomes. This groundbreaking AI technology will allow physicians all over the world to instantly access the latest treatment approaches from the world’s leading centers of excellence for patients similar to the ones they are treating. MORE Health expects that this breakthrough will improve diagnosis and treatment outcomes, particularly in underserved populations globally.“AI is reshaping the whole world, not only in technology but also in healthcare. By utilizing the tremendously high-quality medical data we have accumulated, our AI tools will provide guidance to physicians and their patients worldwide,” said Dr. Robert Warren, MORE Health's Co-Founder and Professor of Surgery, Director of Surgical Oncology Laboratory and past Chief of Surgical Oncology at the UCSF Medical Center.About MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. Since 2013, MORE Health has helped thousands of patients around the world access care in the US.About AAMAFounded in 1979, Asia America MultiTechnology Association (AAMA) is the Silicon Valley’s largest and most established non-profit organization dedicated to prospering the business growth throughout the Asian American high-tech community. With a network of over 10,000 leading executives and investors worldwide, AAMA’s mission is to create a global technology association that foster a broad collaboration platform to integrate the global healthcare resources between Silicon Valley and Asia. Through its diverse spectrum of programs, AAMA provides a forum that highlights the innovations, partnerships and people can exchange and share leading edge solutions across Silicon Valley and Asia.MEDIA CONTACT:MORE Health Representativemedia@morehealth.com
November 5, 2019
San Mateo, CA., November 5, 2019 -- MORE Health, a global healthcare company, announced a strategic collaboration with Japan’s Integrity Healthcare (IH), giving international patients access to the top physicians and services of Integrity Healthcare through MORE Health’s Physician Collaboration Platform™. MORE Health, through its prestigious network of tertiary and quaternary Academic Medical Centers and esteemed physician specialists, delivers a sophisticated version of medical second opinion for its patients, called a collaborative diagnosis (or Co-Diagnosis®). The Co-Diagnosis® service is delivered by a full-featured, intuitive and HIPAA-compliant online platform. Together, with the patient’s treating physicians in their home country, our physician specialists team up to efficiently and effectively deliver a diagnosis and treatment plan, providing the patient with a remote second opinion, saving them time and sometimes, putting their worries at ease.Integrity Healthcare has a wide network of medical institutions and world-renowned specialists providing excellent resources for the treatment of cardiovascular diseases and various cancers including gastrointestinal cancer.Their vision is to create an advanced healthy nation and a new medical system for Japan. The advanced healthy nation that IH wishes for is a society in which people highly value their own healthy minds and bodies, a society in which infrastructure supports people so that even if they have an illness or are coming on in years, they can live with peace of mind. Integrity Healthcare aims to create a new medical system based on the desire to achieve health and peace of mind for all people.“We believe the collaboration between MORE Health and Integrity Healthcare will greatly benefit patients in China,” said Dr. Shinsuke Muto, President of Integrity Healthcare. “By leveraging our expansive medical platforms, we are going to contribute to the synergetic growth of [tele]medicine in both Japan and China for the benefit of our patients.”On Oct 11th, 2019, a joint venture named International Healthcare was formed by MORE Health and Integrity Healthcare. This new service company will draw on both parties’ strengths to bring the world’s top diagnosis and telemedicine services to international patients.“Through collaboration with Integrity Healthcare, we will be able to give our patients access to the best medical resources in Japan, which brings them new choices and new hope,” said Dr. Marc Shuman, MORE Health's Chief Medical Officer and Professor, Department of Medicine and Urology, UCSF.Since 2013, MORE Health has helped thousands of patients around the world access care in the US. Through this partnership, their patients in China are able to access even more of the world’s most preeminent doctors and specialists.About Integrity HealthcareFounded in 2009, Integrity Healthcare Co, Ltd. is engaged in the development of regionally-comprehensive care systems and the development of medical and long-term care coordination systems. In December 2015, funding was received from the Regional Economy Vitalization Corporation of Japan (REVIC), a government investment company, and we have since engaged in the development and dissemination of “YaDoc”, a type of next-generation medical infrastructure in Japan’s medical industry. More at https://www.integrity-healthcare.co.jpAbout MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. More at https://morehealth.com
July 23, 2019
San Mateo CA, July 23, 2019 -- The Children’s Mercy Hospital of Kansas City and MORE Health, a global healthcare company, announced an innovative partnership that provides patients from across the world access to the exceptional physicians of Children’s Mercy Hospital through MORE Health’s Physician Collaboration Platform™.MORE Health, through its prestigious network of tertiary and quaternary Academic Medical Centers and esteemed physician specialists, delivers a sophisticated version of medical second opinion for its patients, called a collaborative diagnosis (or Co-Diagnosis®). The Co-Diagnosis® service is delivered by a full-featured, intuitive and HIPAA-compliant online platform. Together, with the patient’s treating physicians in their home country, our physician specialists team up to efficiently and effectively deliver a diagnosis and treatment plan for the patient. This provides the MORE Health patient with a remote second opinion, saving them time and sometimes, putting their worries at ease.“This partnership allows Children’s Mercy Hospital to bring our clinical innovations to both Chinese patients and Chinese physicians. Without MORE Health’s unique platform, it would be difficult to offer remote second opinions in a way that would be both scalable and reciprocal. Together we can now influence the future of healthcare in China.” said Pamela Frank, Director, International Services at Children's Mercy Hospital.Kids come first at Children’s Mercy. Always have, for more than 120 years. Children aren't just little adults. They require specialized care that can only be offered by doctors, nurses and staff trained in pediatrics. That's why Children’s Mercy is proud to be named one of the best children's hospitals in America by U.S. News and World Report, ranking in all 10 pediatric specialties. Every day employees strive to fulfill their mission:Improve the health and well-being of children by providing comprehensive family-centered health care, committing to the highest level of clinical and psychosocial care, and exhibiting research, educational and service excellence. The scientists at their Children’s Research Institute are relentless in their search for answers and work diligently every single day, making a difference for children today and into the future.“Highly Ranked by US News and World Report in 10 specialties, Children’s Mercy has engaged in meaningful programs and opportunities that improve the lives of children beyond the walls of the hospital. Partnering with MORE Health, together we will improve the health and well-being of children all over the world.” said Ted Bukowski, MORE Health’s Chief Revenue Officer.Since 2013, MORE Health has helped thousands of patients around the world access care in the US. Through this partnership, their patients are able to access even more of the world’s most preeminent doctors and specialists.About Children’s Mercy Hospital of Kansas CityFounded in 1897, Children’s Mercy Hospital of Kansas City is one of the nation’s top pediatric medical centers. With not-for-profit hospitals in Missouri and Kansas, and numerous specialty clinics in both states, Children’s Mercy provides the highest level of care for children from birth through the age of 21.U.S. News & World Reporthas repeatedly ranked Children’s Mercy as one of “America's Best Children's Hospitals.” For the fourth time in a row, Children’s Mercy has achieved Magnet nursing designation, awarded to only about 8 percent of all hospitals nationally, for excellence in quality care. Its faculty of more than 700 pediatric subspecialists and researchers across more than 40 subspecialties are actively involved in clinical care, pediatric research, and educating the next generation of pediatric subspecialists. Thanks to generous philanthropic and volunteer support, Children’s Mercy provides medical care to every child who passes through its doors, regardless of a family’s ability to pay. For more information about Children’s Mercy and its research, visit childrensmercy.org. For breaking news and videos, follow us on Twitter, YouTube and Facebook.About MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. Learn more at https://morehealth.com.
July 17, 2019
San Mateo, CA. July17, 2019 -- UCLA Health and MORE Health, a global healthcare company, announced a strategic alliance that gives patients access to the exceptional physicians and services of UCLA Health through MORE Health’s Physician Collaboration Platform™. MORE Health, through its prestigious network of tertiary and quaternary Academic Medical Centers and esteemed physician specialists, delivers a sophisticated version of medical second opinion for its patients, called a collaborative diagnosis (or Co-Diagnosis®). The Co-Diagnosis® service is delivered by a full-featured, intuitive and HIPAA-compliant online platform. Together, with the patient’s treating physicians in their home country, our physician specialists team up to efficiently and effectively deliver a diagnosis and treatment plan for the patient. This provides the MORE Health patient with a remote second opinion, saving them time and, sometimes, putting their worries at ease.“UCLA Health has a history of high-quality health care that produces exceptional outcomes. Our incredible faculty from the David Geffen School of Medicine enable us to treat the most complex health care needs”, says Michael Burke, Executive Director of UCLA Health International Services. “We are proud to provide health care services to patients around the world. Our partnership with MORE Health will expand our existing second opinion program and allow us to serve our patients in a more flexible way, from the comfort of their home.” For more than 60 years, UCLA Health has provided the best in health care and the latest in medical technology to the people of Los Angeles and throughout the world. Its physicians are world leaders in the diagnosis and treatment of complex illnesses, and its hospitals areconsistently ranked among the best in the nation byU.S. News & World Report. UCLA Health is at the cutting edge of biomedical research, and its doctors and scientists are pioneering work across an astounding range of disciplines, from organ transplantation and cardiac surgery to neurosurgery and cancer treatment and bringing the latest discoveries to virtually every field of medicine.“We are pleased to partner with this comprehensive health care institute to provide the best care possible to our patients,” said Hope Lewis, MORE Health's Co-Founder and CEO, “UCLA Health offers a welcoming and nurturing environment with best-in-class treatment.”Since 2013, MORE Health has helped thousands of patients around the world access care in the US. Through this partnership with UCLA Health, patients are able to access even more of the world’s most preeminent doctors and specialists.About UCLA HealthUCLA Health is among the most comprehensive and technologically advanced health care systems in the world, providing an extraordinary opportunity for the advancement of medicine and improving patient care. UCLA Health includes four hospitals on two campuses — Ronald Reagan UCLA Medical Center; UCLA Medical Center, Santa Monica; Mattel Children’s Hospital UCLA; and Resnick Neuropsychiatric Hospital at UCLA — and more than 170 primary care and specialty clinics throughout Southern California. UCLA Health ranks #1 in Los Angeles, #2 in California and #7 in the nation in U.S. News & World Report’s 2018-19 Best Hospitals survey. More at https://www.uclahealth.org.About MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. More at https://morehealth.com.
July 11, 2019
SAN MATEO, CA, July 11, 2019 -- The University of Chicago Medicine and MORE Health, a global healthcare company, announced a unique collaboration that provides patients from across the world with access to the nationally and internationally recognized physicians of The University of Chicago Medicine through MORE Health’s Physician Collaboration Platform™. MORE Health, through its prestigious network of tertiary and quaternary Academic Medical Centers and esteemed physician specialists, delivers a sophisticated version of medical second opinion for its patients, called a collaborative diagnosis (or Co-Diagnosis®). The Co-Diagnosis® service is delivered by a full-featured, intuitive and HIPAA-compliant online platform. Together, with the patient’s treating physicians in their home country, our physician specialists team up to efficiently and effectively deliver a diagnosis and treatment plan for the patient. This provides the MORE Health patient with a remote second opinion, saving them time and, sometimes, putting their worries at ease.“We are pleased to have found a company like MORE Health to enable UChicago Medicine to provide world-class care to a population of patients we may have otherwise been unable to reach,” said Nida Shekhani, Executive Director of Business Development and International Programs at UChicago Medicine. “The online platform MORE Health has developed is extremely impressive and aligns perfectly with our strategic focus of using technology to improve access and convenience for patients.”The University of Chicago Medicine is advancing the forefront of health every day by bringing research to reality and advanced care closer to its patients. For more than 100 years, UChicago Medicine has been recognized for its groundbreaking research, cutting-edge treatments and innovative care. Three University of Chicago Medicine specialties — cancer (No. 33), gastroenterology and GI surgery (47) andurology (45) — were recognized as being among the best in the country in the 2018-19 U.S. News and World Report rankings. Four other specialties were ranked as high performing — nephrology, neurology and neurosurgery and orthopedics. UChicago Medicine physicians and researchers have helped shape modern medicine and are responsible for pioneering organ transplantation, discovering that cancer is a genetic disease, introducing chemotherapy as a cancer treatment and developing life-changing digestive diseases treatments, among many other breakthroughs. “We are excited to partner with The University of Chicago Medicine using our innovative platform,” said Ted Bukowski, MORE Health SVP and CRO. “Advancing the forefront of medicine allows for the best in class care, and MORE Health is proud to provide such care to its patients.”Since 2013, MORE Health has helped thousands of patients around the world access care in the US. Through this collaboration, their patients are able to access even more of the world’s most preeminent doctors and specialists.About The University of Chicago MedicineThe University of Chicago Medicine, with a history dating to 1927, is a not-for-profit academic medical health system based on the campus of the University of Chicago in Hyde Park, and with hospitals, outpatient clinics and physician practices throughout Chicago and its suburbs. UChicago Medicine unites five organizations to fulfill its tripartite mission of medical education, research and patient care: Pritzker School of Medicine, Biological Sciences Division, Medical Center, Community Health and Hospital Division, and UChicago Medicine Physicians. We have about 1,200 doctors and 3,000 nurses providing care across the full array of medical and surgical specialties. Most of our physicians also serve as faculty members of the Pritzker School of Medicine, teaching the next generation of doctors. Learn more at https://www.uchicagomedicine.orgAbout MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. Learn more at https://morehealth.com
June 27, 2019
San Mateo, CA, June 27, 2019 -- MORE Health, a global healthcare company, announced a collaboration that gives patients from across the world access to the exceptional oncologists of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, through MORE Health’s Physician Collaboration Platform™. City of Hope has one of the largest, most successful bone marrow transplant (BMT) programs in the United States and is MORE Health’s preferred provider in hematologic malignancies (blood cancers). City of Hope is also a leader in innovative treatment for solid tumors, including lung, breast, gastric, brain, thyroid and other types of cancers. This collaboration will provide international patients access to expert interpretation and the best application of targeted therapies and research, as well as to clinical trials for both solid tumors and hematologic malignancies.MORE Health, through its prestigious network of tertiary and quaternary Academic Medical Centers and esteemed physician specialists, delivers a sophisticated version of medical second opinion for its patients called a collaborative diagnosis or Co-Diagnosis®. The Co-Diagnosis® service is delivered by a full-featured, intuitive and HIPAA-compliant online platform, empowering physicians in the U.S. and abroad to efficiently deliver a diagnosis and treatment plan to patients in their home countries.With a new patient referral agreement in place, MORE Health’s international patients now have access to advanced cancer treatment at City of Hope, which is in a region with one of the largest Chinese communities in the U.S. City of Hope provides a unique, culturally sensitive and supportive experience for patients and their families throughout their medical journey.City of Hope is a National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network. Its translational research and personalized treatment protocols advance care throughout the world. Founded in 1913, City of Hope is a leader in BMT and immunotherapy such as CAR T cell therapy. City of Hope’s BMT program is the only program in the nation that has had one-year survival above the expected rate for 14 consecutive years, according to an analysis by the Center for International Blood and Marrow Transplant Research. This means that the institution achieved outcomes that exceeded clinical expectations; this is especially significant because the center traditionally manages the most difficult cases. It also consistently exceeds the national average in patient survivorship. Learn more at www.cityofhope.org“City of Hope is one of the best cancer hospitals in the United States, a leader in bringing new therapies to patients, and is our preferred partner for hematologic malignancies,” said Hope Lewis, MORE Health’s Co-Founder and CEO.Since 2013, MORE Health has helped thousands of patients around the world access care in the U.S. Through this collaboration, their patients are able to access many of the world’s preeminent specialists.About MORE HealthMORE Health, a global digital healthcare company, provides patients with access to the best physicians in the world when needed the most: when faced with a critical, potentially life-changing illness. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make informed decisions regarding their own healthcare. Offering all of the benefits of a second opinion, we ensure that the attending doctor and our expert physician specialist are aligned by jointly developing a diagnosis and treatment plan on our proprietary, cloud-based and HIPAA-compliant Physician Collaboration Platform, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan development. Learn more at https://morehealth.com.MEDIA CONTACT:More Health Representativemedia@morehealth.com
RECENT BLOG
July 21, 2021
Even three years later, Andrew Parker and his University of Chicago Medicine oncologist, Michael Bishop, MD, remain awed by the remarkable turnaround they witnessed thanks to CAR T-cell therapy.In 2016, Parker, then 59, went to his primary care physician about a swollen leg and was stunned to learn he had aggressive acute lymphoblastic leukemia (ALL). The Michigan resident started an array of chemotherapy treatments, but none worked.His health was quickly deteriorating.His medical team suggested he contact Bishop, who was leading a clinical trial on an emerging cancer immunotherapy treatment called CAR T-cell therapy.“They told me Dr. Bishop had something new,” Parker said. “I decided to do it. I had no choice.”CAR T-cell therapy uses re-engineered versions of a patient’s own T-cells to find tumor cells and destroy them with minimal damage to healthy cells.Parker qualified for the trial, but days before the process was scheduled to start, Bishop gave Parker some disappointing news.“We can’t do it,” Bishop told him. The Food and Drug Administration (FDA) had put CAR-T treatments on hold.Devastated, Parker returned home to Michigan believing he didn’t have much longer to live.Bishop, meanwhile, appealed to the FDA, asking the agency to consider Parker for CAR T-cell therapy as a “compassionate use” because of the seriousness of his condition. The FDA gave Bishop the green light.“A week later, Dr. Bishop called and said, ‘Come back! We can start!” Parker said.Parker completed the CAR T-cell therapy treatment. As expected, he was sick for a few days and needed to be monitored in the intensive care unit. But by the third day, he felt fine.A few weeks later, a bone marrow biopsy showed no cancer cells. Parker’s own T-cells had killed the cancer.Since the 2016 treatment, the FDA has approved CAR T-cell therapy for use with certain types of leukemia and lymphoma. UChicago Medicine currently has 15 clinical trials for CAR T-cell therapy for different cancers, including multiple myeloma.Within three months, Parker was healthy enough to return to his job as corporate manager of a tool and die shop. Today, the 61-year-old is back to his normal life — working, traveling, and enjoying life with his fiancé, Mary, who he calls his pillar of support during his cancer battle.“It’s like a miracle,” Parker said.Today, Parker gets regular infusions of immunoglobulin to protect him from infections and illness. A weakened immune system is a side effect of CAR T-cell therapy.Every six months, he makes the seven-hour round-trip drive for a 15-minute appointment with Dr. Bishop, part of his clinical trial commitment.“I see Dr. Bishop, give some blood, and then go home,” he said. “It’s worth every mile.”ABOUT UCHICAGO MEDICINEUChicago Medicine is one of America’s leading academic medical institutions. It comprises the Pritzker School of Medicine, one of the top medical schools in the nation; the University of Chicago Biological Sciences Division, which twelve Noble Prize winners in physiology or medicine have been affiliated with; and the University of Chicago Medical Center, which recently opened the Center for Care and Discovery, a $700 million, 10-story specialty medical facility that focuses on cancer, digestive diseases, neurosciences, advanced surgery, and high-tech medical imaging. UChicago Medicine has 1,300 licensed beds, nearly 1,300 attending physicians, about 2,800 nurses and 1,000 residents and fellows, and offers a full range of specialty-care services for adults and children through more than 40 institutes and centers including an NCI-designated Comprehensive Cancer Center. 9 adult specialties and 2 children’s specialties are ranked nationally by US News and World Report. We are committed to providing the best treatment options as well as personalized services for Chinese patients who come to UChicago Medicine. We are also dedicated to bringing best practices to China and supporting our strategic partners to improve clinical quality and operational effectiveness through tailored consulting and/or training programs. About MORE HealthMORE Health, a global digital health company, provides peace of mind and confidence to patients when they need it most—when facing a serious life-changing illness. Delivering second medical opinions virtually, MORE Health delivers a diagnosis and recommended treatment plan from the world’s best medical minds. This collaborative approach to diagnosis puts the patient at the center of the process—empowering them to make informed decisions regarding their healthcare. Offering all the benefits of a second opinion, the service ensures that the attending doctor and the expert physician specialist are aligned through their proprietary, GDPR- and HIPAA-compliant Physician Collaboration Platform™, thus minimizing errors while also resolving potential conflicts regarding the diagnosis and treatment plan developed. Since 2013, MORE Health has helped patients on six continents and continues its mission to provide clients and their members access to the best medical minds in the world—when they need it most. Offered as an employee benefit or on an individual basis.